Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Bristol-Myers Squibb Opens In Bangalore
by Jean-François Tremblay
March 30, 2009
| A version of this story appeared in
Volume 87, Issue 13
Bristol-Myers Squibb has started operations at its Bangalore R&D center, located on the premises of the Indian biotechnology firm Biocon. The facility, which already employs 270 researchers, was built and is operated by Biocon's contract research subsidiary Syngene. BMS has outsourced work to Syngene for more than 10 years. The 200,000-sq-ft facility will host 360 researchers by year-end and as many as 450 in the future.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter